WilliamGHaynesIIIMDMBChB, FRCPE
Internal Medicine • Iowa City, IASite Head and VP, Novo Nordisk Research Centre Oxford
Dr. Haynes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Hawkins Dr
Iowa City, IA 52242Phone+1 319-356-8469Fax+1 319-353-7340
Education & Training
University of Sheffield School of MedicineClass of 1984
Certifications & Licensure
IA State Medical License 1995 - 2014
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
- Elected Member The American Society for Clinical Investigation, 2006
Clinical Trials
- Drug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With Obesity Start of enrollment: 2011 Mar 01
- Targeting Inflammation to Treat Cardiovascular Aging Start of enrollment: 2012 Sep 01
Publications & Presentations
PubMed
- 201 citationsContrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice.Allyn L. Mark, Richard A. Shaffer, Marcelo L.G. Correia, Donald A. Morgan, Curt D. Sigmund
Journal of Hypertension. 1999-12-01 - 144 citationsSympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications.Graziela Z Kalil, William G. Haynes
Hypertension Research. 2012-01-01 - 95 citationsHomocysteine: Role and implications in atherosclerosisSasidhar Guthikonda, William G. Haynes
Current Atherosclerosis Reports. 2006-03-01
Grant Support
- Renin-Angiotensin-Aldosterone System And Sympathetic Activation In Obesity-HypertNational Heart, Lung, And Blood Institute2010–2011
- Myeloperoxidase Polymorphism On Endothelial Function And Vascular ComplianceNational Center For Research Resources2007
- Sympathetic Control Of Vascular TONE In Obesity: Interaction With HypertensionNational Center For Research Resources2005–2007
- Matrix Metalloproteinases On Endothelial Function In AtherosclerosisNational Center For Research Resources2005–2007
- Effect Of Dietary Fat On Sympathetic Nerve ActivityNational Center For Research Resources2004–2007
- Vascular Consequences Of Sympathetic Neural Activation In ObesityNational Heart, Lung, And Blood Institute2003–2007
- Is Smooth Muscle Dysfunction An Early Event In Atherosclerosis?National Center For Research Resources2006
- Hyperhomocyst(E)Inemia Induced By Methionine LoadingNational Center For Research Resources2004–2006
- Cs-866 In Patients With Established AtherosclerosisNational Center For Research Resources2004–2005
- Vascular Effects Of Homocysteine In HumansNational Heart, Lung, And Blood Institute1998–2005
- Sympathetic Control Of Vascular TONE In ObesityNational Center For Research Resources2004
- Fish Oil On Endothelial Funciton And Vascular Compliance In AtherosclerosisNational Center For Research Resources2004
- Xanthine Oxidase Products In Modulation Of Endothelial DysfunctionNational Center For Research Resources2000–2002
- Sympathetic Neurovascular Function In Diabetes MellitusNational Center For Research Resources2000–2002
- Homocysteine And Endothelial Function In HumansNational Center For Research Resources1998–2002
- Endothelial Function In Humans Following A High Fat MealNational Center For Research Resources1998–2000
- Cardiovascular, Autonomic &Metabolic Effects Of Troglitazone In HypertensionNational Center For Research Resources1998–2000
- Sympathetic Neurovascular Function In Diabetes MellitusNational Institute Of Neurological Disorders And Stroke1998–1999
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
